Replies to post #215550 on Cytodyn Inc (CYDY)

[Learning53]

Covid may "promote breast cancer reactivation."

From
The abstract of:
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
2020 OCT 30
https://investorshub.advfn.com/secure/post_reply.aspx?message_id=170508937

From the post I'm responding to.
Here's a quote from the abstract:

"Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (NETs). The presence of NETs and of a pro-inflammatory microenvironment may therefore promote breast cancer re activation, increasing the risk of pulmonary metastasis."

A further, unanswered question: Can Covid act as a catalyst to reawaken other types of cancer cells? Not a pleasant thought.

Further potential reasons why Leronlimab's availability is imperative.

Long on CytoDyn and especially LERONLIMAB!

imo

[theswordman]

The most obvious reason is CYDY mngmt NEVER applied for EUA.
Or are you still wanting to believe ANOTHER nodder lie=--when he stated CYDY applied for EUA--only to be caught in another lie--he finally mumbled "we asked"
What a joke--the people that believe the lies. The people that don't understand FDA requires. The people that believe Phillipine Airways is a great partner.

[daemon57]

MRI Reveals Significant

Hang on.. didn't an MRI also reveal stat sig for Leronlimab at 350 for Nash???
Just saying..

GTLA REAL LONGS